Search

everythinglearnresearchcommunity

for

Search:↓

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Estrogen alone can lower testosterone in some transfeminine people.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

The Leechbook shows how hair and sexual health were key to medieval masculinity and some remedies may still be useful.

Accurate diagnosis and early specialist referral are crucial for managing 46,XY Disorders of Sex Development.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Hair loss affects women's self-esteem; treatments like minoxidil can help.